IL10 and psoriasis: In the early course of the disease, psoriasis patients express high levels of IFN-γ, which shifted toward IL-10 secretion in chronic patients, suggesting a possible shift from Th1 to Th2 response as an adaptation of the immune system to down-regulate inflammatory Th1 response [93].